Walnut Creek, CA, United States of America

Franco J Duarte

This inventor holds 15 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 6 EPO patents. Top assignee: Nektar Therapeutics. Active years: 2013-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Franco J Duarte. Retrieved from https://idiyas.com/inventor/franco-j-duarte

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 1)

% Patents Active = 73.3

CIPO Patents = 2

EPO Patents = 6 (Patent Applications = 5)

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 19(Granted Patents)

Location History:

Huntsville, AL (US) (2013 - 2017)
Millbrae, CA (US) (2017)
Walnut Creek, CA (US) (2018 - 2022)

Company Filing History:

15 out of 415

Nektar Therapeutics

patents

Years Active: 2013-2022

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11241415 - N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the κ opioid receptor (2022-02-08),

2. 11111214 - Kappa opioid agonists and uses thereof (2021-09-07),

3. 10881738 - Oligomer-beta blocker conjugates (2021-01-05),

4. 10865186 - Opioid agonists and uses thereof (2020-12-15),

5. 10407416 - Kappa opioid agonists and uses thereof (2019-09-10),

6. 10322107 - N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the kappa opioid receptor (2019-06-18),

7. 10251959 - Oligomer-beta blocker conjugates (2019-04-09),

8. 10081602 - Opioid agonists and uses thereof (2018-09-25),

9. 9815824 - Kappa opioid agonists and uses thereof (2017-11-14),

10. 9782488 - Oligomer-beta blocker conjugates (2017-10-10),

11. 9688638 - Opioid agonists and uses thereof (2017-06-27),

12. 9233165 - Oligomer-aryloxy-substituted propanamine conjugates (2016-01-12),

13. 9107956 - Oligomer-protease inhibitor conjugates (2015-08-18),

14. 9095620 - Reagents (2015-08-04),

15. 8598364 - Oligomer-protease inhibitor conjugates (2013-12-03),

Title: Innovations and Contributions of Franco J Duarte

Introduction

Franco J Duarte is a prominent inventor based in Walnut Creek, CA (US). He has made significant contributions to the fields of drug discovery and pharmacotherapy, holding a total of 15 patents. His work focuses on developing novel compounds that have potential applications in various scientific domains.

Latest Patents

Among his latest patents, Duarte has developed N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives, which act as agonists for the κ opioid receptor. These compounds, along with their pharmaceutically acceptable salts and solvates, are relevant to drug discovery, pharmacotherapy, physiology, and organic chemistry. Another notable patent involves kappa opioid agonists, which includes compounds of Formula I and their pharmaceutically acceptable salts and solvates. These compounds also have applications in drug discovery, pharmacotherapy, physiology, organic chemistry, and polymer chemistry.

Career Highlights

Duarte is currently associated with Nektar Therapeutics, where he continues to innovate and contribute to the pharmaceutical industry. His extensive experience and expertise in the field have positioned him as a key player in the development of new therapeutic agents.

Collaborations

Some of his notable coworkers include Neel Kumar Anand and Wen Zhang, who collaborate with him on various projects within the company.

Conclusion

Franco J Duarte's work exemplifies the impact of innovative thinking in the pharmaceutical sector. His patents and ongoing research contribute significantly to advancements in drug discovery and pharmacotherapy.

Profile summary based on public USPTO records.